Evidence map›Paper›PMID 22835465›Full record

ArticleThe American journal of medicine2012

Prevalence and morbidity associated with muscle cramps in patients with cirrhosis.

Hemant Chatrath, Suthat Liangpunsakul, Marwan Ghabril, Julie Otte, Naga Chalasani, Raj Vuppalanchi

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02221570 naunknown statusnot on this mapstarted 2014, after this paper: background citation

A Randomized Placebo Controlled Study of Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis

TypeinterventionalSponsorTanta UniversityRan2014 to 2014Enrolled100ConditionsMuscle Cramps, Liver CirrhosisArmsBaclofen
NCT05724485 phase4completednot on this mapstarted 2023, after this paper: background citation

Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis

TypeinterventionalSponsorMahidol UniversityRan2023 to 2023Enrolled48ConditionsMuscle Cramp, Cirrhosis, Quality of LifeArmsBranched-chain Amino Acid, Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Guideline
  2. Non-drug therapies for the secondary prevention of lower limb muscle cramps.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Muscle Cramps Do Not Improve With Correction of Vitamin D Insufficiency.WMJ : official publication of the State Medical Society of Wisconsin · 2017
    Trial
  7. Update on the Complications and Management of Liver Cirrhosis.Medical sciences (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Relationship Between Muscle Cramps and Diabetic Retinopathy in Patients with Type 2 Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Article
  14. Hospice care for end stage liver disease in the United States.Expert review of gastroenterology & hepatology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hemant ChatrathDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Suthat Liangpunsakul
Marwan Ghabril
Julie Otte
Naga Chalasani
Raj Vuppalanchi
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Patient-Oriented Research of Liver DiseaseK24DK069290 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CHALASANI, NAGA P · 2005 to 2014
$1.4M
NIDDK NIH HHS K24 DK069290
6 · The paper itself

Abstract

purposePatients with cirrhosis often experience muscle cramps with varying severity. We investigated the factors associated with the prevalence and morbidity associated with muscle cramps.

methodsA total of 150 adult patients with cirrhosis were enrolled consecutively. Cramp questionnaire with visual analogue scale for pain, Chronic Liver Disease Questionnaire (CLDQ), and blood for measurement of 25-(OH) vitamin D levels were obtained after informed consent.

resultsA total of 101 patients (67%) reported muscle cramps in the preceding 3 months. Patients with cramps had significantly lower serum albumin (3.1±0.6 g/dL vs 3.3±0.7 g/dL, P=.04) and CLDQ scores (107±37 vs 137±34, P<.0001) compared with those without cramps. The median composite symptom score, defined as product of frequency and severity of cramps, in the study cohort was 12 with a range of 0.3 to 200. There were no clinical or biochemical predictors for occurrence of any cramps or severe cramps (composite symptom score>12). Muscle cramps (P<.001) and hepatic encephalopathy (P=.009) were associated independently with decreased CLDQ scores. Vitamin D deficiency was seen in 66% of the study cohort, but the serum 25-(OH) vitamin D levels were not significantly different between patients with and without cramps (18.0±8.9 ng/mL vs 19.6±9.5 ng/mL, P=.49).

conclusionsMuscle cramps are associated with significantly diminished quality of life in patients with cirrhosis. More research is needed to better understand their mechanism to develop effective treatment.

Indexed as

AdultAgedFemaleHumansLinear ModelsLiver CirrhosisLogistic ModelsMaleMiddle AgedMultivariate AnalysisMuscle CrampPain MeasurementPrevalenceProspective StudiesQuality of LifeRisk Factors

Identifiers

PMID22835465
PMCPMC3932181
OpenAlexW2070936769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.